A prescription weight management medication delivered as part of a physician-managed program, if appropriate for you.
Semaglutide works with the body's natural appetite-regulation system. Prescribed and dose-managed by a licensed provider, it can help you feel full sooner, stay full longer, and quiet the mental noise around food. This is a monthly program with clinician oversight, a titration schedule, and ongoing support — not a one-off order.
Size
Monthly shipment — 4-week vial supply per titration scheduleSemaglutide isn’t open for enrollment yet — join the waitlist and we’ll email you the moment we go live.
WHAT TO EXPECT
Weight management with semaglutide takes months to unfold. The medication supports the underlying biology; how quickly and how much you change depends on your starting point, how you tolerate the titration, and the daily habits around eating and movement that the medication makes easier — not automatic.
WEEKS 1–8
Your provider starts you at a low dose and steps up on a schedule designed for you. Most people notice reduced appetite and quieter food thoughts within the first few weeks. Mild gastrointestinal side effects (nausea, upset stomach, constipation) are most common early and generally improve as your body acclimates. Consistent check-ins with your provider matter most here — dose adjustments, side effect management, and sustainable eating patterns.
MONTHS 2–4
As your dose settles into a therapeutic range and side effects continue to fade, many patients see steady, gradual change. The medication supports what your body is doing — a reduced-calorie eating pattern and regular movement remain the actual mechanism. Your provider may continue titrating or hold at a maintenance dose depending on your response.
MONTHS 4+ AND LONG-TERM
Longer-term outcomes depend on staying with the program and building durable habits around it. Published clinical trials of FDA-approved semaglutide products have documented meaningful weight loss over 12+ months when combined with lifestyle changes. Individual results vary substantially — some patients continue to lose, others plateau, some discontinue for cost, tolerability, or life reasons. Your provider will discuss what a realistic 6- and 12-month outlook looks like at your consultation.
Outcomes vary widely. Clinical trials of the FDA-approved branded formulations of semaglutide have shown average weight loss on the order of 10–15% in adults with obesity or overweight plus a weight-related medical condition, when combined with a reduced-calorie diet and increased physical activity. Compounded semaglutide contains the same active ingredient but has not been studied in the same trials. Your HerTeleMeds provider will set realistic expectations at your consultation.
ABOUT THE TREATMENT
Semaglutide is a GLP-1 receptor agonist — it mimics the action of a naturally-occurring hormone that regulates appetite and blood sugar. The result is slower gastric emptying (you feel full longer), reduced appetite signaling (you feel full sooner), and quieter food-related preoccupation. Combined with a reduced-calorie eating pattern and regular movement, it can produce gradual, sustained weight change over months.
Getting a GLP-1 prescription is one piece of the picture. Durable outcomes come from the combination: the medication supporting your biology, a titration schedule that lets your body adjust, ongoing provider check-ins to manage side effects and adjust dose, and the lifestyle work — protein-forward eating, adequate hydration, resistance training — that protects lean mass while you lose fat. HerTeleMeds is set up as a program, not a single order.
Semaglutide is prescribed based on your provider's clinical judgment following a health assessment. Providers generally consider adults with a BMI in the range typically associated with obesity, or overweight combined with a weight-related medical condition, who have tried lifestyle changes without sustained results. Eligibility criteria are reviewed as part of your intake. Not everyone who inquires will be a fit — safety comes first.
HOW TO USE
STEP 01
Semaglutide is self-administered as a subcutaneous injection once per week. Your provider will walk you through technique and dose in your onboarding, and you'll get written instructions with your first shipment.
STEP 02
Rotate between the abdomen (at least 2 inches from your navel), the front of your thigh, and the back of your upper arm each week. This reduces skin irritation and supports consistent absorption.
STEP 03
Your dose starts low and steps up on the schedule your provider designed for you. Don't change your dose without their guidance — going faster increases side effects without accelerating results.
STEP 04
Keep your vial refrigerated (36–46°F). Do not freeze. Do not use a vial that has been frozen or looks discolored. Discard sharps in an appropriate container.
STEP 05
Your provider will want a brief check-in — via secure message or scheduled consult — before you move to a higher dose. This is where you flag side effects, discuss what's working, and adjust the plan.
Do not share your medication or injection supplies with anyone else. Contact your HerTeleMeds provider promptly if you experience severe or persistent side effects.
GLP-1 receptor agonist — mimics a natural appetite-regulation hormone
Once-weekly injection — a manageable weekly ritual, not a daily one
All medication, all provider visits, and shipping included in your $179/mo subscription — no per-vial charges, no surprise fees
Any-dose plan — from 0.25 mg/wk starter to 2.4 mg/wk maintenance, your dose adjustments are all covered
Month-to-month commitment, 30-day cancellation notice
How HerTeleMeds Works
Answer a few questions about your skin and medical history.
A U.S.-licensed provider reviews your information within 24 hours.
If prescribed, your compounded formula is made fresh and arrives discreetly — often within 2–3 days.
One application a day. Results build gradually with consistent use.
Product details
FAQ
Compounded semaglutide contains the same active ingredient (semaglutide) as the FDA-approved branded products, but the compounded formulation itself is not FDA-approved. Compounded medications are prepared by a licensed compounding pharmacy under your provider's prescription. The branded products (Ozempic® and Wegovy®) are manufactured by Novo Nordisk A/S, which is not affiliated with HerTeleMeds. Your provider will discuss the distinctions at your consultation so you can make an informed decision.
Individual results vary substantially. Published clinical trials of FDA-approved semaglutide products, combined with a reduced-calorie diet and increased physical activity, have shown average weight loss on the order of 10–15% in adults with obesity or overweight plus a weight-related medical condition over 12+ months. Compounded semaglutide has not been evaluated in those trials specifically. Your provider will discuss realistic expectations based on your starting point, health history, and lifestyle.
Both are effective. Tirzepatide activates two appetite pathways (GLP-1 and GIP); semaglutide activates one (GLP-1). Head-to-head trial data on the FDA-approved branded products has generally shown somewhat greater average weight loss with tirzepatide, though individual response varies. Cost, tolerability, and your provider's clinical judgment about your specific situation all factor in. This is exactly what the consultation is for.
Your subscription is billed monthly, but shipping runs on a schedule tied to your titration dose — not the calendar. Your provider prescribes the vial strength appropriate for your current dose, and the pharmacy ships when you're due for a refill based on your protocol. Some months you may receive a shipment; some you may not. Your provider drives the fulfillment schedule based on where you are in the program.
Message your provider through your account. Dose changes are part of the standard program — your provider will adjust based on how you're tolerating the medication and progressing. Pauses (for travel, illness, insurance timing, or life reason) are possible; discuss the timing with your provider so we can adjust your shipping schedule accordingly.
HSA and FSA acceptance varies by plan administrator and may require documentation from your provider. If your card is not accepted at checkout, you can pay with a regular card and submit for reimbursement through your plan — HerTeleMeds provides itemized receipts on request. Coverage is not guaranteed.
HerTeleMeds is a cash-pay program for compounded weight management. Compounded medications are typically not covered by insurance, and we don't submit claims. The advantage of cash-pay is transparent monthly pricing with no prior-authorization delays.
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These are usually dose-related, improve with time or dose adjustment, and are the primary reason providers titrate gradually. Injection site reactions (mild redness, itching) are also common and typically resolve on their own. Serious side effects are rare but require prompt contact with your provider — see the safety information above.
Start with a brief online intake covering your health history and weight-management goals. A HerTeleMeds provider will review your responses and determine whether compounded semaglutide is appropriate. If prescribed, you'll begin a physician-managed program with monthly billing, a titration schedule, and ongoing check-ins built for how this medication actually works.
Start your intakePrescription required. Consultation included. Not available in all states. Available only to patients who meet clinical eligibility criteria as determined by a licensed HerTeleMeds provider.
